Statistics from Altmetric.com
In the UK National Health Service (NHS), primary prevention of cardiovascular disease (which encompasses diabetes and renal disease too) is now achieving the status afforded to secondary prevention 10 years ago. The Department of Health vascular risk checks programme1 is welcomed to strategically reduce health inequalities, which are precipitated largely by cardiovascular disease. Cardiovascular morbidity and mortality are, in principle, preventable.2 In 2005 in England, there were 171 021 deaths from circulatory diseases (accounting for 40% of all deaths).3 Additionally, it is responsible for one-fifth of all hospital admissions and incurs an NHS expenditure of £30 billion annually. Therefore, prevention is beneficent not only to the individual but also to the wider economy. The government has recently recommended the introduction of a universal risk assessment and management programme for people aged 40 to 74 years.1 The magnitude of this task must not be underestimated, as a number of challenges will need to be addressed before such a programme can be widely implemented.
Accepting a NHS shift from illness management to health protection requires a paradigm shift in public perception. Widespread publicity and health promotion must accompany cardiovascular prevention strategies, similar to campaigns supporting initiatives such as cervical screening. The voluntary sector may launch and sustain such public campaigns, but the role and responsibility of the NHS as a partner in publicity will require clarification.
With a population aware and engaged with the principles of vascular risk assessment, next comes the issue of whom and how to target risk assessment. …
Competing interests: KCRP is clinical lead for Staying Healthy and Lead for the CVD Strategy for West Midlands Strategic Health Authority, a member of NICE guideline groups on smoking cessation, chest pain and cardiovascular prevention, a member of the National Heart Forum which focuses on prevention of CVD and a steering group member of the Cardio and Vascular Coalition. RM is a member of NICE guideline groups on Lipid Modification and Familial Hyperlipidaemia. PG is a member of the NICE Guideline group for Lipid Modification and cardiovascular prevention. KK has received funding from Department of Health for a diabetes screening and intervention study, an NIHR diabetes prevention programme grant and advised the UK National Screening Committee on the Vascular Risk Assessment Programme. RC is screening lead for Department of Health West Midlands and co-lead for the CVD Strategy. KCRP, RM, PG and KK are members of the South Asian Health Foundation, which is a stakeholder to several NICE guidelines.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.